Margot Sanger-Katz

@sangerkatz.bsky.social

Covering health care at @nytimes.com. Enjoy metaphors. Dislike mixed metaphors. Reach me on Signal: sangerkatz.01

Easily one of my favorite stories we've ever worked on. Have you ever... not gotten around to opening your mail for a week or two? That's the kind of thing that will get a low-income family kicked off benefits. The GOP reconciliation bill would ramp up such hurdles.

Margot Sanger-Katz@sangerkatz.bsky.social · last yr.

If you want to think more about how paperwork can prevent eligible people from getting benefits, this piece 2020 piece with @emmbadger.bsky.social has a fun quiz, a large survey, and lots of research, and features photos of our boss's mail. www.nytimes.com/interactive/...

If you want to think more about how paperwork can prevent eligible people from getting benefits, this piece 2020 piece with @emmbadger.bsky.social has a fun quiz, a large survey, and lots of research, and features photos of our boss's mail. www.nytimes.com/interactive/...

Take the Quiz: Could You Manage as a Poor American? (Published 2020)

See whether you make the kinds of mistakes that can cost poor families food or health insurance.

nytimes.com

If a non-expansion state newly adopts expansion, hospitals/other providers see those SDPs at 110% of Medicare fall to 100%. Creates another disincentive for states to take up expansion along with other provisions including elimination of existing fiscal incentives to encourage expansion (7/x)

There's relatively little substantive content in the text of the MFN EO, but this section is emblematic of the many, many questions people should have about its scope. Where will the Secretary get this pricing information? How will they decide "price targets"? For which drugs? Which countries? Etc.

Within 30 days of the date of this order, the Secretary shall, in coordination with the Assistant to the President for Domestic Policy, the Administrator for the Centers for Medicare and Medicaid Services, and other relevant executive department and agency (agency) officials, communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations.